Alpha- Antitrypsin Deficiency Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Alpha- Antitrypsin Deficiency Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Alpha- Antitrypsin Deficiency Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Alpha- Antitrypsin Deficiency Treatment Overall Market Size
2.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size: 2023 VS 2030
2.2 Global Alpha- Antitrypsin Deficiency Treatment Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Alpha- Antitrypsin Deficiency Treatment Players in Global Market
3.2 Top Global Alpha- Antitrypsin Deficiency Treatment Companies Ranked by Revenue
3.3 Global Alpha- Antitrypsin Deficiency Treatment Revenue by Companies
3.4 Top 3 and Top 5 Alpha- Antitrypsin Deficiency Treatment Companies in Global Market, by Revenue in 2023
3.5 Global Companies Alpha- Antitrypsin Deficiency Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Alpha- Antitrypsin Deficiency Treatment Players in Global Market
3.6.1 List of Global Tier 1 Alpha- Antitrypsin Deficiency Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Alpha- Antitrypsin Deficiency Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Alpha- Antitrypsin Deficiency Treatment Market Size Markets, 2023 & 2030
4.1.2 CT-2009
4.1.3 POL-6014
4.1.4 ARO-AAT
4.1.5 ALNAAT-02
4.1.6 Others
4.2 By Type - Global Alpha- Antitrypsin Deficiency Treatment Revenue & Forecasts
4.2.1 By Type - Global Alpha- Antitrypsin Deficiency Treatment Revenue, 2019-2024
4.2.2 By Type - Global Alpha- Antitrypsin Deficiency Treatment Revenue, 2025-2030
4.2.3 By Type - Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Alpha- Antitrypsin Deficiency Treatment Market Size, 2023 & 2030
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Alpha- Antitrypsin Deficiency Treatment Revenue & Forecasts
5.2.1 By Application - Global Alpha- Antitrypsin Deficiency Treatment Revenue, 2019-2024
5.2.2 By Application - Global Alpha- Antitrypsin Deficiency Treatment Revenue, 2025-2030
5.2.3 By Application - Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Alpha- Antitrypsin Deficiency Treatment Market Size, 2023 & 2030
6.2 By Region - Global Alpha- Antitrypsin Deficiency Treatment Revenue & Forecasts
6.2.1 By Region - Global Alpha- Antitrypsin Deficiency Treatment Revenue, 2019-2024
6.2.2 By Region - Global Alpha- Antitrypsin Deficiency Treatment Revenue, 2025-2030
6.2.3 By Region - Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Alpha- Antitrypsin Deficiency Treatment Revenue, 2019-2030
6.3.2 US Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.3.3 Canada Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.3.4 Mexico Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Alpha- Antitrypsin Deficiency Treatment Revenue, 2019-2030
6.4.2 Germany Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.4.3 France Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.4.4 U.K. Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.4.5 Italy Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.4.6 Russia Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.4.7 Nordic Countries Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.4.8 Benelux Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Alpha- Antitrypsin Deficiency Treatment Revenue, 2019-2030
6.5.2 China Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.5.3 Japan Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.5.4 South Korea Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.5.5 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.5.6 India Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Alpha- Antitrypsin Deficiency Treatment Revenue, 2019-2030
6.6.2 Brazil Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.6.3 Argentina Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Revenue, 2019-2030
6.7.2 Turkey Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.7.3 Israel Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.7.4 Saudi Arabia Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
6.7.5 UAE Alpha- Antitrypsin Deficiency Treatment Market Size, 2019-2030
7 Alpha- Antitrypsin Deficiency Treatment Companies Profiles
7.1 Adverum Biotechnologies, Inc.
7.1.1 Adverum Biotechnologies, Inc. Company Summary
7.1.2 Adverum Biotechnologies, Inc. Business Overview
7.1.3 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.1.4 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global Market (2019-2024)
7.1.5 Adverum Biotechnologies, Inc. Key News & Latest Developments
7.2 Alnylam Pharmaceuticals, Inc.
7.2.1 Alnylam Pharmaceuticals, Inc. Company Summary
7.2.2 Alnylam Pharmaceuticals, Inc. Business Overview
7.2.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.2.4 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global Market (2019-2024)
7.2.5 Alnylam Pharmaceuticals, Inc. Key News & Latest Developments
7.3 Applied Genetic Technologies Corporation
7.3.1 Applied Genetic Technologies Corporation Company Summary
7.3.2 Applied Genetic Technologies Corporation Business Overview
7.3.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.3.4 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Revenue in Global Market (2019-2024)
7.3.5 Applied Genetic Technologies Corporation Key News & Latest Developments
7.4 Arrowhead Pharmaceuticals, Inc.
7.4.1 Arrowhead Pharmaceuticals, Inc. Company Summary
7.4.2 Arrowhead Pharmaceuticals, Inc. Business Overview
7.4.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.4.4 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global Market (2019-2024)
7.4.5 Arrowhead Pharmaceuticals, Inc. Key News & Latest Developments
7.5 Carolus Therapeutics, Inc.
7.5.1 Carolus Therapeutics, Inc. Company Summary
7.5.2 Carolus Therapeutics, Inc. Business Overview
7.5.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.5.4 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global Market (2019-2024)
7.5.5 Carolus Therapeutics, Inc. Key News & Latest Developments
7.6 Cevec Pharmaceuticals GmbH
7.6.1 Cevec Pharmaceuticals GmbH Company Summary
7.6.2 Cevec Pharmaceuticals GmbH Business Overview
7.6.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.6.4 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Revenue in Global Market (2019-2024)
7.6.5 Cevec Pharmaceuticals GmbH Key News & Latest Developments
7.7 Dicerna Pharmaceuticals, Inc.
7.7.1 Dicerna Pharmaceuticals, Inc. Company Summary
7.7.2 Dicerna Pharmaceuticals, Inc. Business Overview
7.7.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.7.4 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global Market (2019-2024)
7.7.5 Dicerna Pharmaceuticals, Inc. Key News & Latest Developments
7.8 Digna Biotech, S.L.
7.8.1 Digna Biotech, S.L. Company Summary
7.8.2 Digna Biotech, S.L. Business Overview
7.8.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.8.4 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Revenue in Global Market (2019-2024)
7.8.5 Digna Biotech, S.L. Key News & Latest Developments
7.9 Editas Medicine, Inc.
7.9.1 Editas Medicine, Inc. Company Summary
7.9.2 Editas Medicine, Inc. Business Overview
7.9.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.9.4 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global Market (2019-2024)
7.9.5 Editas Medicine, Inc. Key News & Latest Developments
7.10 Grifols, S.A.
7.10.1 Grifols, S.A. Company Summary
7.10.2 Grifols, S.A. Business Overview
7.10.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.10.4 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Revenue in Global Market (2019-2024)
7.10.5 Grifols, S.A. Key News & Latest Developments
7.11 Inhibrx
7.11.1 Inhibrx Company Summary
7.11.2 Inhibrx Business Overview
7.11.3 Inhibrx Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.11.4 Inhibrx Alpha- Antitrypsin Deficiency Treatment Revenue in Global Market (2019-2024)
7.11.5 Inhibrx Key News & Latest Developments
7.12 Intellia Therapeutics, Inc.
7.12.1 Intellia Therapeutics, Inc. Company Summary
7.12.2 Intellia Therapeutics, Inc. Business Overview
7.12.3 Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.12.4 Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global Market (2019-2024)
7.12.5 Intellia Therapeutics, Inc. Key News & Latest Developments
7.13 International Stem Cell Corporation
7.13.1 International Stem Cell Corporation Company Summary
7.13.2 International Stem Cell Corporation Business Overview
7.13.3 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.13.4 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Revenue in Global Market (2019-2024)
7.13.5 International Stem Cell Corporation Key News & Latest Developments
7.14 Ionis Pharmaceuticals, Inc.
7.14.1 Ionis Pharmaceuticals, Inc. Company Summary
7.14.2 Ionis Pharmaceuticals, Inc. Business Overview
7.14.3 Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.14.4 Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global Market (2019-2024)
7.14.5 Ionis Pharmaceuticals, Inc. Key News & Latest Developments
7.15 Kamada Ltd.
7.15.1 Kamada Ltd. Company Summary
7.15.2 Kamada Ltd. Business Overview
7.15.3 Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.15.4 Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Revenue in Global Market (2019-2024)
7.15.5 Kamada Ltd. Key News & Latest Developments
7.16 Polyphor Ltd.
7.16.1 Polyphor Ltd. Company Summary
7.16.2 Polyphor Ltd. Business Overview
7.16.3 Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.16.4 Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Revenue in Global Market (2019-2024)
7.16.5 Polyphor Ltd. Key News & Latest Developments
7.17 ProMetic Life Sciences Inc.
7.17.1 ProMetic Life Sciences Inc. Company Summary
7.17.2 ProMetic Life Sciences Inc. Business Overview
7.17.3 ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.17.4 ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global Market (2019-2024)
7.17.5 ProMetic Life Sciences Inc. Key News & Latest Developments
7.18 rEVO Biologics, Inc.
7.18.1 rEVO Biologics, Inc. Company Summary
7.18.2 rEVO Biologics, Inc. Business Overview
7.18.3 rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.18.4 rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global Market (2019-2024)
7.18.5 rEVO Biologics, Inc. Key News & Latest Developments
7.19 Sangamo BioSciences, Inc.
7.19.1 Sangamo BioSciences, Inc. Company Summary
7.19.2 Sangamo BioSciences, Inc. Business Overview
7.19.3 Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.19.4 Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global Market (2019-2024)
7.19.5 Sangamo BioSciences, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Alpha- Antitrypsin Deficiency Treatment Market Opportunities & Trends in Global Market
Table 2. Alpha- Antitrypsin Deficiency Treatment Market Drivers in Global Market
Table 3. Alpha- Antitrypsin Deficiency Treatment Market Restraints in Global Market
Table 4. Key Players of Alpha- Antitrypsin Deficiency Treatment in Global Market
Table 5. Top Alpha- Antitrypsin Deficiency Treatment Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Alpha- Antitrypsin Deficiency Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Alpha- Antitrypsin Deficiency Treatment Revenue Share by Companies, 2019-2024
Table 8. Global Companies Alpha- Antitrypsin Deficiency Treatment Product Type
Table 9. List of Global Tier 1 Alpha- Antitrypsin Deficiency Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alpha- Antitrypsin Deficiency Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Alpha- Antitrypsin Deficiency Treatment Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Alpha- Antitrypsin Deficiency Treatment Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Alpha- Antitrypsin Deficiency Treatment Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Alpha- Antitrypsin Deficiency Treatment Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2025-2030
Table 30. Adverum Biotechnologies, Inc. Company Summary
Table 31. Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 32. Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn) & (2019-2024)
Table 33. Adverum Biotechnologies, Inc. Key News & Latest Developments
Table 34. Alnylam Pharmaceuticals, Inc. Company Summary
Table 35. Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 36. Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn) & (2019-2024)
Table 37. Alnylam Pharmaceuticals, Inc. Key News & Latest Developments
Table 38. Applied Genetic Technologies Corporation Company Summary
Table 39. Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 40. Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn) & (2019-2024)
Table 41. Applied Genetic Technologies Corporation Key News & Latest Developments
Table 42. Arrowhead Pharmaceuticals, Inc. Company Summary
Table 43. Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 44. Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn) & (2019-2024)
Table 45. Arrowhead Pharmaceuticals, Inc. Key News & Latest Developments
Table 46. Carolus Therapeutics, Inc. Company Summary
Table 47. Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 48. Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn) & (2019-2024)
Table 49. Carolus Therapeutics, Inc. Key News & Latest Developments
Table 50. Cevec Pharmaceuticals GmbH Company Summary
Table 51. Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 52. Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn) & (2019-2024)
Table 53. Cevec Pharmaceuticals GmbH Key News & Latest Developments
Table 54. Dicerna Pharmaceuticals, Inc. Company Summary
Table 55. Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 56. Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn) & (2019-2024)
Table 57. Dicerna Pharmaceuticals, Inc. Key News & Latest Developments
Table 58. Digna Biotech, S.L. Company Summary
Table 59. Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 60. Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn) & (2019-2024)
Table 61. Digna Biotech, S.L. Key News & Latest Developments
Table 62. Editas Medicine, Inc. Company Summary
Table 63. Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 64. Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn) & (2019-2024)
Table 65. Editas Medicine, Inc. Key News & Latest Developments
Table 66. Grifols, S.A. Company Summary
Table 67. Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 68. Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn) & (2019-2024)
Table 69. Grifols, S.A. Key News & Latest Developments
Table 70. Inhibrx Company Summary
Table 71. Inhibrx Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 72. Inhibrx Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn) & (2019-2024)
Table 73. Inhibrx Key News & Latest Developments
Table 74. Intellia Therapeutics, Inc. Company Summary
Table 75. Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 76. Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn) & (2019-2024)
Table 77. Intellia Therapeutics, Inc. Key News & Latest Developments
Table 78. International Stem Cell Corporation Company Summary
Table 79. International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 80. International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn) & (2019-2024)
Table 81. International Stem Cell Corporation Key News & Latest Developments
Table 82. Ionis Pharmaceuticals, Inc. Company Summary
Table 83. Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 84. Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn) & (2019-2024)
Table 85. Ionis Pharmaceuticals, Inc. Key News & Latest Developments
Table 86. Kamada Ltd. Company Summary
Table 87. Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 88. Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn) & (2019-2024)
Table 89. Kamada Ltd. Key News & Latest Developments
Table 90. Polyphor Ltd. Company Summary
Table 91. Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 92. Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn) & (2019-2024)
Table 93. Polyphor Ltd. Key News & Latest Developments
Table 94. ProMetic Life Sciences Inc. Company Summary
Table 95. ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 96. ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn) & (2019-2024)
Table 97. ProMetic Life Sciences Inc. Key News & Latest Developments
Table 98. rEVO Biologics, Inc. Company Summary
Table 99. rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 100. rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn) & (2019-2024)
Table 101. rEVO Biologics, Inc. Key News & Latest Developments
Table 102. Sangamo BioSciences, Inc. Company Summary
Table 103. Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offerings
Table 104. Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue (US$, Mn) & (2019-2024)
Table 105. Sangamo BioSciences, Inc. Key News & Latest Developments
List of Figures
Figure 1. Alpha- Antitrypsin Deficiency Treatment Segment by Type in 2023
Figure 2. Alpha- Antitrypsin Deficiency Treatment Segment by Application in 2023
Figure 3. Global Alpha- Antitrypsin Deficiency Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Alpha- Antitrypsin Deficiency Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Alpha- Antitrypsin Deficiency Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Alpha- Antitrypsin Deficiency Treatment Revenue in 2023
Figure 8. By Type - Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2019-2030
Figure 9. By Application - Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2019-2030
Figure 10. By Type - Global Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2019-2030
Figure 12. By Application - Global Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2019-2030
Figure 14. By Region - Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2019-2030
Figure 15. By Country - North America Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2019-2030
Figure 16. US Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2019-2030
Figure 20. Germany Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 21. France Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2019-2030
Figure 28. China Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. India Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2019-2030
Figure 34. Brazil Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2019-2030
Figure 37. Turkey Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Alpha- Antitrypsin Deficiency Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Inhibrx Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 57. ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 58. rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 59. Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Industry Market Size
